Sulfapyridine and Vomiting: An Experimental Study of the Mechanism in the Dog * by Sadusk, Joseph F. et al.
SULFAPYRIDINE AND VOMITING
AN EXPERIMENTAL STUDY OF THE MECHANISM IN THE DOG*
JOSEPH F. SADUSK JR., JOHN W. HIRSHFELD, AND ANNE SEYMOUR
It is generally conceded that nausea with vomiting is the most
commontoxic manifestation ofsulfapyridine therapy and may appear
in approxdmately 60 to 70 per cent of cases treated with the drug.
Occasionally the vomiting is so severe as to make necessary the
cessation oftherapy.
Explanations proposed for the mechanism of this vomiting fall
into two groups, namely, a local effect upon the gastro-intestinal
tract and a central effect upon the vomiting center. The latter view
is supported bythework of Marshall and Long,' who have observed
that vomiting is produced both in dogs and man when sodium sulfa-
pyridine is given intravenously. That this explanation may not be
entirely correct, however, has been suggested by Haviland and
Blake,' who found that the sulfapyridine concentration in vomitus
of patients receiving sulfapyridine by a parenteral route-only may be
considerably higher than that in the blood.
In addition, we have observed that sulfapyridine is excreted into
the stomach of the dog with surprising rapidity following the intra-
venous injection of sodium sulfapyridine. In Table 1 are sum-
marized the results of ten experiments in which a 5 per cent solution
of sodium sulfapyridine was injected intravenously into dogs until
vomiting was produced. As soon as possible after the act of vomit-
ing, a specimen of blood was taken from the dog. In both this and
the vomitus the concentration of non-acetylated sulfapyridine was
determined by the method of Marshall and Litchfield.4 The time
at which emesis occurred after beginning the injection of sulfapyri-
dine is also recorded. The results show that within 4 to 52 minutes
after beginning the injection of the drug, sulfapyridine was fre-
quently present in the vomitus in a concentration nearly as high as
* From the Departments of Internal Medicine and of Surgery, Yale University
School of Medicine. The expense of this study was defrayed by the Clinical
Research and Teaching Fund of the Yale University School of Medicine. The
material of this paper was presented in abstract form before the American Society
for Clinical Investigation in May, 1940.YALE JOURNAL OF BIOLOGY AND MEDICINE
TABLE 1
THE RAPID EXCRETION OF SULFAPYRIDINE INTO THE STOMACH AFTER INTRAVENOUS
ADMINISTRATION OF SODIUM SULFAPYRIDINE TO DOGS
Time after 5%o sodium
beginning injection sulfapyridine Sulfapyridine conc.
Dog Weight ofsod. suJfapyridine injected Blood Vomitus
No. kg. minutes cc. mg. % mg. %
7 12.1 38 65.0 23.0 21.5
8 10.3 44 60.0 23.0 3.4
10 6.5 13 35.0 26.5 24.0
10 6.5 8 30.0 21.5 3.0
11 19.0 4 45.0 17.0 9.5
12 11.2 31 70.0 21.5 23.0
15 17.4 52 110.0 29.0 23.5
16 6.4 9 35.0 32.0 24.0
18 8.8 24 60.0 30.0 24.4
19 12.4 13 65.0 32.0 11.2
that in the blood. These observations, then, would leave open the
question as to whether the excretion of sulfapyridine into the gastric
juice might not play some part in the mechanism of nausea and
vomiting.
We have, therefore, systematically studied the problem in the
dog, which is an excellent animal to use in an experimental study of
this nature, since it exhibits definite signs of nausea, as evidenced by
salivation, licking, chewing, and apprehension, and vomits readily
and with satisfactory consistency under treatment with sulfapyridine.
Experiments dealing with (1) the relation between blood concentra-
tion of sulfapyridine and emesis in normal dogs, (2) the effect of
total gastrectomy and complete gastro-intestinal evisceration on the
emetic action of sulfapyridine, and (3) the response of the vomiting
center to the direct application of sulfapyridine, are. recorded in this
paper.
In these studies dogs were selected which consistently vomited
when given sulfapyridine, since one may occasionally find dogs in
which the emetic action of the drugs is absent or not manifest until
toxic cerebral symptoms are produced.
Experimental
Relation of bloodconcentration ofsulfapyridine to emesis indogs
In order to establish the range of blood concentration of sulfa-
pyridine within which intact dogs vomit, experiments were carried
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out in which a S per cent solution of sodium sulfapyridine* was
injected intravenously in increments of from 5 to 20 cc. (depending
upon the size of the dog) and at intervals of from 3 to 10 minutes.
A typical experiment is illustrated in the following protocol.
Protocol 1. Intravenous injection of 5% sodium sulfapyridine in a
normal dog.
Dog No. 1, female, mongrel terrier, weight 8.5 kg.
January 9:
2:46 P. M.-5.0 cc. of 5% sodium sulfapyridine solution intravenously.
2:51 P. M.-5.0 cc. of 5% sodium sulfapyridine solution intravenously.
2:55 P. M.-Sulfapyridine blood concentration 6.8 mg.%o.
2:56 P. M.-5.0 cc. of 5% sodium sulfapyridine solution intravenously.
3:01 P. M.-5.0 cc. of 5%o sodium sulfapyridine solution intravenously.
3:05 P. M.-Sulfapyridine blood concentration 15.8 mg.%o.
3:06 P. M.-5.0 cc. of 5%b sodium sulfapyridine solution intravenously.
3:11 P. m.-5.0 cc. of 5% sodium sulfapyridine solution intravenously.
3: 16 P. M.-Sulfapyridine blood concentration 22.8 mg.%7.
3:17 P. M.-5.0 cc. of 5%o sodium sulfapyridine solution intravenously.
3:21 P. M.-5.0 cc. of 5% sodium sulfapyridine solution intravenously.
3:22 P. m.-Slight licking, apprehensive.
3:24 P. M.-Moderate licking, followed shortly after by an abdominal con-
traction.
3: 26 P. M.-Sulfapyridine blood concentration 28.8 mg.%o.
3:27 P. m.-5.0 cc. of 5%o sodium sulfapyridine solution intravenously.
3:29 P.M.-Vomited.
3:31 P. M.-Sulfapyridine blood concentration 30.6 mg.%o.
3:34 P. M.-Vomited again.
In Table 2 are summarized the results of 29 such experiments
upon 16 normal and intact dogs. Of these 16 dogs, 13 vomited at
a sulfapyridine concentration in the blood of from 17 to 36.5 mg.
per cent. The remaining three dogs, Nos. 13, 14, and 17, did not
vomit before symptoms of central nervous system intoxication
became evident, at which time the injections were terminated. The
sulfapyridine blood concentration in these three dogs ranged from
33 to 41 mg. per cent at this time.
Of the 13 dogs that vomited, two (Nos. 6 and 20), in the initial
test, failed to vomit prior to the onset of convulsions but did vomit
in subsequent experiments before intoxication of the central nervous
* The sodium sulfapyridine used in this investigation was supplied by Merck &
Co., Inc., through the courtesy of Dr. D. F. Robertson.
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TABLE 2
RELATION OF SULFAPYRIDINE CONCENTRATION IN THE BLOOD TO VOMITING IN DOGS
FOLLOWING THE INTRAVENOUS ADMINISTRATION OF SODIUM SULFAPYRIDINE
5% Sod.sulfa.. Sulfapyridine
Dog Weight pyridineiinjected conc.snblood"
No. kg. cc. mg. % Emesis
1 .8.5 . 40.0 .............29.6 ... +
1 .8.5 . 35.0 .............25.8** ... +
1 .8.5 . 45.0 .............30.6 ... +
1 .8.5 . 45.0 .............29.5*** ... +
5 .11.0 . 45.0 .............21.5 ... +
6 .9.1 . 700t ..............30.0 ....-
6 .9.1 .75.0 .............33.0 .. . + 7.12.1 .65.0 .............. 23.0 . +
8 .10.3 .60.0 .............23.0 . +
10 .6.5 .35.0 .............26.5. + 10 .6.5 .30.0 ..............21.5 . +
11 .19.0 .45.0 .............17.0. +
12 .11.2 .70.0 ...............21.5 .. + 13 .6.5 .35.0t .............33.0 ...-
14 .6.6 ................55t ............. ...............0. 14 .6.6 ................55.ot ...............41.0 . 15 .17.4 . 110.0 .............29.0 ... +
15 .17.4 . 120.0 .............29.0 ... +
16 .6.4 . 35.0 .............36.5 ...±+
16 .6.4 . 35.0 .............32.0.+
16 .6.4 . 30.0 .............30.0 ... +
17 .4.0 . 35.0t .............37.0 ....-
17 .4.0 . 35.0t .............40.0 .....-
18 .8.8 . 60.0 .............30.0 ..+
18 .8.8 .40.0 .............20.5 . +
19 .12.4 .65.0 .............32.0. +
20 .3.8 .40.0t .............29.0 ...............
20 .3.8 .30.0 .............18.0. +
20 3.8 25.0 .............23.0 +
* Blood sample taken either at time of emesis or at onset of convulsions if vomiting
did not occur.
** 100 cc. of 20 mg. %b sulfapyridine put into stomach by tube before starting
experiment.
*** Suspension of 1.0 gm. sulfapyridine in 100 cc. of water put into stomach by tube
before starting experiment.
tConvulsions, experiment terminated.
system became manifest. It should be mentioned, perhaps, that both
these dogs and the other three which failed to vomit, appeared to be
of nervous temperament and rather high-strung.
Experiments carried out on one dog (No. 1) revealed that the
onset of vomiting and its relation to blood concentration of sulfa-
pyridine was not materially changed by the prior instillation into the
stomach of a solution or suspension containing up to as much as 1 per
cent of sulfapyridine in water. These experiments are presented in
Table 2.SULFAPYRIDINE AND VOMITING
Experiments ongastrectomized and eviscerated dogs
In order to exdude the possible local effect of sulfapyridine on
the stomach as part of the mechan'ism involved in the vomiting
caused by this drug, five similar experiments were carried out on
three gastrectomized dogs.
These dogs were subjected to total gastrectomy, and, 3 to 12
weeks later, intravenous injection of sodium sulfapyridine was car-
ried out bythe same procedure as that used in the normal dogs. All
three dogs vomited within the range of blood concentrations found
to cause emesis in normal dogs. The data are shown in Table 3.
The protocol of a representative experiment follows:
Protocol 2. Intravenous injection of 5% sodium sulfapyridine in a
gastrectomized dog.
Dog No. 2, female, mongrel beagle, weight 11.0 kg. (prior to operation).
October 27:
Total gastrectomy under intravenous nembutal anesthesia.
December 18:
1:50 P. M.-10.0 cc. of 5%o sodium sulfapyridine solution intravenously.
1:52 P. M.-Sulfapyridine blood concentration 2.8 mg.%.
1:55 P. M.-5.0 cc. of 5% sodium sulfapyridine solution intravenously.
1:58 P. M.-Sulfapyridine blood concentration 10.5 mg.%. -
2:03 P. M.- 5.0 cc. of 5% sodium sulfapyridine solution intravenously.
2:15 P. M.-Sulfapyridine blood concentration 19.3 mg.%.
2:15 P. M.-5.0 cc. of sodium sulfapyridine solution intravenously.
2:19 P. M.-Moderate licking and salivation. Sulfapyridine blood concen-
tration 25.6 mg.%o.
2:20 P. M.-5.0 cc. of sodium sulfapyridine solution injected intravenously,
followed by marked licking, salivation, yawning, and appre-
hension.
2:25 P. M.-5.0 cc. of sodium sulfapyridine solution intravenously.
2:26 P. M.-Dog presented typical actions of vomiting, producing 5 to 10
cc. of yellow mucus, which contained no sulfapyridine on
analysis.
2:30 P. M.-Actions of vomiting repeated. Sulfapyridine blood concentra-
tion 34.0 mg.%o.
Further experiments of this type, of necessity acute, were per-
formed in five dogs following removal of the entire gastro-intestinal
tract. The operative technic in general was that described by Eggles-
ton and Hatcher.1 In this procedure the entire stomach, large and
small intestine, spleen, and most of the pancreas were removed.
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TABLE 3
VOMITING IN DOGS GIVEN SODIUM SULFAPYRIDINE INTRAVENOUSLY FOLLOWING TOTAL
GASTRECTOMY
Weight 5% Sod. sulfa- Sulfapyridinecone.
Dog ofdog* pyridine injected inbloodatemesis
No. kg. cc. Emesis mg. %
2 .............. 11.0 30.0 + 22.4
2 . .. 11.0 35.0 + 34.0
2 .............. 11.0 31.0 + 23.1
3 .............. 9.3 40.0 + 29.6
4 .............. 10.8 40.0 + 24.3
*Weight of dogs prior to gastrectomy, following which they lost considerable
weight.
Chloroform was employed as the anesthetic. Results essentially
similar to those recorded above were obtained (Table 4). The
protocol of a typical experiment is outlined below.
Protocol 3. Intravenous injection of 5% sodium sulfapyridine in an
eviscerated dog.
Dog No. 19, female, white spitz, weight 12.4 kg.
April 22:
1:38-1:51 P. M.: Dog vomited at sulfapyridine blood concentration of 32.0
mg.%, following the intravenous injection of a total of 65.0 cc.
of 5%o sodium sulfapyridine.
April 24:
1:47-2:28 P.M.: Under light chloroform anesthesia, the gastro-intestinal
tract from rectum to esophagus, including the spleen, and the
greater part of the pancreas, was removed.
2:38 P. M.-Dog walking about.
2:42 P. M.-20.0 cc. of 5%o sodium sulfapyridine solution intravenously.
2:45 P. M.-20.0 cc. of 5% sodium sulfapyridine solution intravenously.
2:48 P. M.-10.0 cc. of 5% sodium sulfapyridine solution intravenously.
2:50 P. M.- Dog apprehensive, licking, retched.
2:51 P. M.-10.0 cc. of 5% sodium sulfapyridine solution intravenously.
2:54 P. M.-Dog apprehensive, licking, retched.
2:56 P. M.-10.0 cc. of 5% sodium sulfapyridine solution intravenously.
2:58Y2 P. M.-Vomiting movements.
2:59 P. M.-Sulfapyridine blood level 21.5 mg.%. Animal sacrificed.
In these experiments, two of the five dogs did not vomit. One
dog (No. 12) fell into shock during operation and remained so
depressed after operation that failure to vomit is not surprising. TheSULFAPYRIDINE AND VOMITING
TABLE 4
VOMITING IN DOGS GIVEN SODIUM SULFAPYRIDINE INTRAVENOUSLY FOLLOWING
TOTAL REMOVAL OF GASTRO-INTESTINAL TRACT
Before evisceration After evisceration
5% Sod. Sulfa- 5% Sod. Sulfa-
Wt. sulfa- pyridine sulfa- pyridine
of pyridine conc. in pyridine conc. in
Dog dog injected blood injected blood
No. kg. cc. Emesis mg. %o cc. Ernesis mg. %
5 11.0 45.0 ± 21.5 40.0 + 23.0
9 18.5 (a) (a) (a) 140.0 51.0*
12 11.2 70.0 + 21.5 95.0 -t 40.0*
15 17.4 110.0 + 29.0 100.0 + 31.5
19 12.4 65.0 + 32.0 70.0 + 21.5
(a) Not tested for vomiting before evisceration.
* Blood sample taken after end of intravenous injection, at which time there were
generalized convulsions.
tDog in shock during the experiment and very depressed.
other dog (No. 9) had not been tested for vomiting with sulfa-
pyridine before operation and it seems possible that it would fall
iInto the small group of dogs that fail to vomit with the drug prior
to the onset of convulsions. It may also be observed that there is
no essential difference in the blood concentration of sulfapyridine at
the time of emesis in the dogs either prior to or after evisceration.
Results of these experiments, then, would certainly indicate that
vomiting caused by sulfapyridine is not dependent upon the presence
of sulfapyridine in the gastro-intestinal tract, whether ingested or
excreted into the stomach.
Experiments on the vomiting center
A study of the possible direct action of sulfapyridine upon the
vomiting center was then undertaken. In 1891 Thumas6 described
an area situated in the floor of the fourth ventricle in the region of
the dorsal nucleus of the vagus nerve which he called the vomiting
center. More specifically, this is a physiological area in the midline
of the floor of the fourth ventricle measuring about 5 mm. in length
and 2 mm. in width and extending to a point about 2 mm. posterior
to the calamus scriptorius. He found that destruction of this area
caused inhibition ofvomitingand that the local application of minute
quantities of apomorphine to this point caused prompt emesis in
dogs. This center may be exposed with moderate difficulty in the
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living dog in a two-stage operation as originally described by
Hatcher and Weiss.2
Our procedure was, briefly, as follows: A dog of suitable size
and disposition was trained for several weeks to lie quietly in the
prone position with head extended between the fore legs. Under
sterile precautions and deep nembutal anesthesia, an incision in the
midline was made extending from the nuchal crest to the level of the
third cervical vertebra and carried down to the skull. Following
initial trephine, the bone over the inferior portion of the cerebellum
was now rongeured away so that an opening of from 1.5 to 2 cm. was
made. The wound was then closed with interrupted silk sutures,
taking special precautions to secure perfect hemostasis.
Twenty-four hours later with the dog in prone position, the
wound was opened, under local novocaine anesthesia, exposing the
dura. This and the arachnoid were opened exposing the cerebellum
which could be gently lifted up, thus bringing into view the floor of
the fourth ventride.
Various concentrations of sulfapyridine in normal saline, ranging
from 10 to 100 mg. per cent, were now dropped in turn from a
micro-pipette on to the vomiting center. Following this, solutions
of apomorphine in normal saline, beginning with a concentration as
low as 0.0001 mg. of apomorphine per 1.0 cc. of solution were
applied to the vomiting center in a similar manner. When emesis
had been produced, the operative wound was closed and sodium
sulfapyridine was then administered intravenously to the point of
vomiting.
The protocol of a typical experiment is given below:
Protocol 4. Direct application of sulfapyridine to the vomiting center.
Dog No. 7, female, white spitz, weight 12.1 kg.
March 6:
2:26-3:04 P. M.-Dog vomited at sulfapyridine blood concentration of 23.0
mg.%, following the intravenous administration of 65.0 cc. of
5% sodium sulfapyridine.
March 11:
3:00 P. M.-Under intravenous nembutal anesthesia, trephine of skull with
exposure of the dura. Wound sutured.
March 12:
1: 35-2: 14 P. M.-Under local infiltration novocaine anesthesia, the floor of
the fourth ventricle was exposed.
2:15 P. M.-Vomiting center mechanically stimulated with a foreign object.
Dog vomited.
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2:18 P. M.-Saline washed over vomiting center. No effect.
2:20 P. M.-10 mg.%o sulfapyridine applied. Repeated. No effect.
2:26 P. M.-30 mg.%o sulfapyridine applied. Repeated. No effect.
2:33 P. M.-50 mg.%o sulfapyridine applied. Repeated. No effect.
2:37 P. M.-100 mg.%o sulfapyridine applied. Repeated. No effect.
2:45 P. M.-0.00005 mg. (0.5 cc. solution) apomorphine applied.
2:47 P. M.-0.00004 mg. (0.4 cc. solution) apomorphine applied.
2:51 P. M.-Dog retched.
2:51 P. M.-0.0002 mg. (0.2 cc. solution) apomorphine applied.
2:52 P. M.-0.0003 mg. (0.3 cc. solution) apomorphine applied.
2:52Y2 P. M.-Dog vomited vigorously.
2:55 P. M.-Operative wound closed.
3:50-4:17 P. M.-Intravenous injection of 60.0 cc. of 5% sodium sul-
fapyridine solution. Dog vomited at 4:18 P. M., sulfapyridine
blood level 30.0 mg.%o.
Theresults ofthreesuch experiments aresummarizedinTable 5.
It may be observed that none of these dogs vomited with the local
application of sulfapyridine. Two of the dogs vomited following
the local application of apomorphine in quantities of 0.0005 (0.0002
and 0.0003) and 0.007 mg., respectively. The failure of the
remaining dog to vomit we believe to be due to a web of fibrin over
the medulla which was impossible to remove. All three dogs
vomited promptly upon the intravenous administration of sodium
sulfapyridine.
These experiments would suggest that sulfapyridine vomiting is
Inot due to a direct action upon the vomiting center. This statement,
of course, assumes that sulfapyridine will penetrate to the vomiting
center as rapidly as apomorphine, but direct proof of this is lacking.
Discussion
The present explanation is that the act of vomiting, in general,
is dependent upon three factors: (1) coordinated actions of the
muscles of the stomach, esophagus, and abdominal wall; (2) a
center' in the medulla, which discharges impulses along efferent
fibers in the phrenic, sympathetic, and cranial nerves; and (3) the
stimulation of this vomiting center by afferent impulses arising in
any of the viscera or even in other cerebral centers. This vomiting
center may also be stimulated directly by certain agents, carried to it
in the blood stream, such as apomorphine, emetine, and picrotoxin.
In regard to the mechanism ofvomiting due specifically to sulfa-
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pyridine, it would appear, with the experimental evidence offered
above, that it is dependent upon an indirect stimulation of the vomit-
ing center, mediated either through reflexes arising from some organ
other than the gastro-intestinal tract or through action of the drug
on other cerebral centers. This interpretation obviously depends
upon the assumption that sulfapyridine directly applied to the vomit-
ing center actually penetrates as does apomorphine.
The fact that both man and dog vomit following the intravenous
administration of the drug is not sufficient evidence for assuming
that sulfapyridine acts directly upon the vomiting center.
The exact site of origin of the reflex stimulation by sulfapyridine
on the vomiting center is not clear at the present time and further
investigation of this problem is in progress.
Summary and coiwlusions
1. Following the intravenous injection of a 5 per cent solution
of sodium sulfapyridine, dogs were found to vomit at a sulfapyridine
concentration in the blood of from 17 to 36.5 mg. per cent. Occa-
sionally, dogs were found that did not vomit, but exhibited signs of
central nervous system intoxication when the blood sulfapyridine
reached a sufficiently high level.
2. Sulfapyridine is readily excreted into the stomach after the
intravenous injection of a S per cent solution of sodiumsulfapyridine.
3. Removal of the stomach, and even of the entire gastro-
intestinal tract including the spleen and the greater part of the pan-
creas, does not inhibit the act of vomiting when sodium sulfapyridine
is given intravenously in dogs.
4. Direct application of sulfapyridine, in a concentration as high
as 100 mg. per cent, to the vomiting center does not cause vomiting,
whereas similar application of apomorphine to the vomiting center
does cause emesis.
5. The above facts indicate that sulfapyridine vomiting in dogs
is not dueeither to local action in the stomach or to direct action upon
the vomiting center. They further suggest that the vomiting is
mediated through a reflex stimulation of the vomiting center, which
certainly is not exclusively from the gastro-intestinal tract but may
arise from some other site or sites.
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